After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
Medera is focused on eradicating cardiovascular diseases with a range of gene- and cell-based approaches in combination with bioengineered human-based technology.
The transaction is intended to provide Brains with access to public capital markets to support its pharmaceutical manufacturing operations and drug development pipeline.